PMC5437432_01
Fluorescein angiography showed profound macular and peripheral ischemia in the early phase (left), in the middle phase (middle), and in the late phase (right, composite view).
cop-0008-0271-g01.jpg
PMC5437432_01_cop-0008-0271-g01.jpg
F1
Fluorescein angiography (FAG) showed an acute BRVO with ischemia in the macular area and along the inferior temporal retinal arcade (Fig. 1).
Intravitreal injections, development of BCVA and CRT, and corresponding OCT images between April 2014 and October 2016.
cop-0008-0271-g02.jpg
PMC5437432_01_cop-0008-0271-g02.jpg
F2
Optical coherence tomography (OCT) analysis detected a central retinal thickness (CRT) of 546 microm (Fig. 2). At the last visit, ME had again completely resolved and BCVA increased to 0.6 (Fig. 2).
Follow-up fluorescein angiography showed profound macular and peripheral ischemia in the early phase (left), in the middle phase (middle), and in the late phase (right, composite view).
cop-0008-0271-g03.jpg
PMC5437432_01_cop-0008-0271-g03.jpg
F3
A follow-up FAG in August 2014 and in September 2016 (Fig. 3) showed no changes in central retinal ischemia status; there was neither a decrease nor an increase in the size of the central ischemic retinal area.